About this trial
Chronic hypoparathyroidism is a rare condition in which the parathyroid glands do not make enough parathyroid hormone (PTH). PTH helps control the levels of calcium and phosphate in the blood. When there is not enough PTH, calcium levels can become too low and phosphate levels can become too high. This may cause symptoms such as tingling, muscle cramps, weakness, or other health problems.
The most common cause of chronic hypoparathyroidism is surgery in the neck area. It can happen after thyroid surgery, surgery on the parathyroid glands, or other operations in the neck.
At the moment, most patients are treated with calcium and vitamin D tablets. These treatments help control calcium levels, but they cannot fully replace the normal effects of PTH in the body. A medicine that contains a form of human PTH is available for some patients, but it is not yet the standard treatment for everyone.
This registry collects medical information and follows patients over time. Its aim is to better understand patients' symptoms, possible long-term health problems, treatments, and overall health. A group of patients who have had their thyroid removed but do not have hypoparathyroidism will also be included for comparison.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
diagnosis of chronic hypo- or pseudohypoparathyroidism > 6 months or diagnosis of pseudohypoparathyroidism
age >= 18 yrs.
residing in Germany
Written consent for patients capable of giving informed consent
Disqualifiers
Minors and patients with severe mental illnesses, or patients who are unable to provide written informed consent.
h/o thyroidektomy with thyroid hormone replacement
age >= 18 yrs.
residing in Germany
Trial population
Patients within the area of Augsburg and southern Germany
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
long-term comorbidities in hypoparathyroidism
compared with a controll group
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital Augsburg
Lead sponsor
Wuerzburg University Hospital
Collaborator
Ascendis Pharma Endocrinology Division A/S
Collaborator